Video & Transcript Research : 'FDA'

Page 46 of 63
CA
Transcript Highlights:
  • The bill could unintentionally capture a wide range of tools, including low-risk technologies, FDA-reviewed
  • We urge the author to consider clarifying that FDA-regulated devices and research-only AI are deemed
Summary: The committee heard several AI- and consumer-protection-related bills, with extensive testimony from authors, supporters, and industry opponents. SB 53 by Senator Wiener would create transparency requirements for large AI developers, including disclosure of safety and security protocols, reporting of critical safety incidents, whistleblower protections, and the CalCompute public cloud. Supporters said it is a narrower, transparency-based follow-up to last year’s vetoed AI safety bill, while opponents argued it still relies too much on company size, could expose trade secrets, and should be narrowed further. The committee approved SB 53 on a do-pass-as-amended vote to Appropriations, with the roll held open for absent members. SB 766 by Senator Allen would codify the FTC’s Cars Rule and create a three-day cooling-off period for certain used-car purchases, along with stronger disclosure rules on pricing, add-ons, and government affiliation claims. Supporters said it would save consumers money and time and help buyers avoid bad deals, while dealer and industry groups said amendments addressed many of their concerns. Several former opponents moved to neutral, and the committee passed SB 766 unanimously as amended to Appropriations. SB 7 by Senator McNerney would regulate automated decision-making systems in employment by requiring notice, human review for discipline and termination, and limits on predictive behavior analysis. Labor and consumer advocates supported the bill as a safeguard against biased or overly automated workplace decisions, while employer and industry groups raised concerns about scope, notice burdens, and the predictive-analysis ban. The committee passed SB 7 to Appropriations on a 4-2 vote, with the roll held open. SB 833, also by Senator McNerney, would require human oversight of AI used in critical infrastructure, along with training and system assessments; it drew limited opposition focused on scope, and the committee passed it as amended to Appropriations on a 5-0 vote, also holding the roll open. Later, the committee took up SB 11, which would address AI-generated voice, image, and video cloning and deepfakes by clarifying likeness protections, requiring consumer warnings, and addressing misuse and evidence tampering. Supporters framed it as a targeted response to nonconsensual deepfakes, while industry groups said recent amendments improved the bill but still had concerns about penalties and warning language. The committee also heard SB 720, the Safer Streets Act, which would let cities opt into a revised red-light camera system that shifts from driver to owner liability, removes facial identification, makes violations civil rather than criminal, and directs revenue toward transportation safety projects; the author presented the bill, but the transcript ends before any final action on SB 720.
TX

Texas 89th Regular

89th Legislative Session Apr 30th, 2025

Texas House Floor Meeting

Transcript Highlights:
  • Members, this exempts small boilers, not broilers, using FDA-regulated medical devices.
  • This bill allows emergency responders and other public entities the option to stock and administer any FDA-approved
Bills: HB24, HB45, HB15, HB35, HB38, HB47, HB318, HB349, HB554, HB1359, HB1373, HB1647, HB2254, HB2259, HB2853, HB3073, HB3088, HB353, HB355, HB786, HB762, HB705, HB932, HB849, HB 1160, HB 1119, HB1612, HB3041, HB713, HB3104, HB3970, HB3962, HB5061, HB4042, HB4115, HB4490, HB1731, HB1705, HB2607, HB3556, HB138, HB3689, HB1788, HB1887, HB1914, HB2402, HB2306, HB1809, HB2350, HB3000, HB3237, HB3326, HB3211, HB 1056, HB2081, HB2187, HB3092, HB3308, HB3526, HB3750, HB3527, HB4219, HB4230, HB4290, HB5238, HB4804, HB4749, HCR6, HCR12, HCR34, HCR50, HCR55, HCR58, HCR70, HCR71, HCR72, HCR74, HCR75, HCR78, HCR80, HCR93, HCR100, HCR107, HCR116, HCR117, HCR90, SB1806, SB783, SB1271, SB326, SB1637, SB769, SB897, SB1035, SB1706, SB1185, SB1194, SB384, SB1426, SB1468, SB1215, SB1066, SB599, SB1930, SB2065, SB767, SB1619, SB1738, HB1500, HB718, HB23, HB34, HB 119, HB 128, HB 130, HB132, HB2756, HB166, HB406, HB186, HB331, HB380, HB1583, HB1584, HB621, HB303, HB552, HB366, HB463, HB 1211, HB1327, HB1461, HB923, HB1760, HB2467, HB5333, HB1592, HB1576, HB1552, HB2018, HB3511, HB1781, HB2013, HB2340, HB2508, HB2970, HB865, HB2851, HB3385, HB3336, HB3309, HB 1127, HB 1232, HB1397, HB4236, HB4041, HB1965, HB2730, HB3698, HB3699, HB163, HB201, HB272, HB405, HB519, HB654, HB694, HB791, HB 1136, HB 1240, HB 1266, HB 1275, HB1437, HB1532, HB1675, HB1842, HB1868, HB1894, HB1943, HB1990, HB2029, HB2061, HB2286, HB2523, HB2622, HB2652, HB2692, HB2842, HB2885, HB3016, HB3096, HB3248, HB3255, HB3479, HB3611, HB3623, HB3803, HB3804, HB3805, HB3806, HB3810, HB3816, HB4129, HB4163, HB4187, HB4238, HB4454, HB4588, HB4643, HB4738, HB4739, HB4945, HB5015, HB5616, HB1749, HB1775, HB 118, HB1762, HB2520, HB24, HB45, HB15, HB35, HB38, HB47, HB318, HB349, HB554, HB1359, HB1373, HB1647, HB2254, HB2259, HB2853, HB3073, HB3088, HB353, HB355, HB786, HB762, HB705, HB932, HB849, HB 1160, HB 1119, HB1612, HB3041, HB713, HB3104, HB3970, HB3962, HB5061, HB4042, HB4115, HB4490, HB1731, HB1705, HB2607, HB3556, HB138, HB3689, HB1788, HB1887, HB1914, HB2402, HB2306, HB1809, HB2350, HB3000, HB3237, HB3326, HB3211, HB 1056, HB2081, HB2187, HB3092, HB3308, HB3526, HB3750, HB3527, HB4219, HB4230, HB4290, HB5238, HB4804, HB4749, HCR6, HCR12, HCR34, HCR50, HCR55, HCR58, HCR70, HCR71, HCR72, HCR74, HCR75, HCR78, HCR80, HCR93, HCR100, HCR107, HCR116, HCR117, HCR90
MN

Minnesota 2025-2026 Regular Session

House Ways and Means Committee 4/23/25

Ways and Means

Transcript Highlights:
  • did have a bill hearing, um, in the committee to, uh, request MnDOT and the Met Council, uh, give the FDA
  • We had a bill hearing, um, in the committee to, uh, request MnDOT and the Met Council give the FDA notice
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Advanced Information Technology, the Internet and Cybersecurity Jun 21st, 2026 at 01:00 pm

Joint Committee on Advanced Information Technology, the Internet and Cybersecurity

Transcript Highlights:
  • as regulations are implemented to share insights from the field, help align with federal positions, FDA
Keywords: 995, all
Summary: The committee held a hearing on several artificial intelligence bills, opening with remarks about the 9/11 anniversary and then broad statements from the co-chairs about AI’s promise and risks. Chair Farley-Bouvier and Senator Moore emphasized the need for guardrails, transparency, and worker and consumer protections, while Senator Finegold described Senate Bill 37, which would create a framework for AI model training with safety assessments, audits, incident reporting, Attorney General oversight, and workforce reporting. Members also discussed Massachusetts’ position relative to other states and the need for state action in the absence of federal regulation. A large portion of the hearing focused on the Fair Act, House 77 and Senate 35, which would limit workplace surveillance, restrict collection of biometric and location data, require notice and human review for automated employment decisions, and protect workers from retaliation. Labor leaders, including AFL-CIO, AFSCME, AFT, SEIU, building trades, and other worker representatives, testified in support, describing harms from bossware, automated benefits denials, hiring and promotion screening, scheduling, and monitoring in workplaces ranging from health care and education to manufacturing and construction. They argued that AI systems are already affecting wages, benefits, safety, and job security, and that Massachusetts should act now to set clear rules. The committee also heard testimony on House Bill 74, which would require informed consent and clear contract terms for digital replicas of voices and likenesses, with SAG-AFTRA representatives supporting the bill as a protection for performers and creators. Another major topic was Senate Bill 51 on social media algorithm accountability and transparency; child safety advocates, researchers, and a public health expert described harms from engagement-based algorithms, including exposure to harmful content, eating disorders, and youth mental health impacts, and supported independent audits and public reporting. A few industry and civil liberties witnesses supported regulation but urged balance, warning against overly burdensome rules while acknowledging the need for privacy, transparency, and accountability. No votes or final committee actions were taken in the hearing excerpt.
LA

Louisiana 2026 Regular Session

House of Representatives May 7th, 2026

Louisiana House Floor Meeting

Transcript Highlights:
  • allows Louisiana to join a consortium of other states working with pharmaceutical companies to get FDA
Bills: HR252, HR253, HR254, HR255, HR256, HCR103, HCR104, HR244, HR245, HR246, HR247, HR248, HR249, HR250, HR251, HCR101, HCR102, SCR40, SCR60, SB112, SB131, SB145, SB194, SB268, SB307, SB312, SB319, SB333, SB341, SB346, SB464, SB466, SB488, SB495, SB503, SB507, SB509, HR9, HR196, HCR27, HCR28, HCR50, HCR62, HCR67, HCR71, HCR78, HCR81, SCR20, HB123, HB251, HB625, HB662, HB709, HB769, HB775, HB783, HB895, HB1011, HB1057, HB1155, HB1186, HB1224, HB1245, HB1247, HB1253, HB1254, HB1255, HB1256, SB8, SB10, SB11, SB12, SB13, SB14, SB16, SB17, SB18, SB20, SB21, SB22, SB40, SB48, SB55, SB69, SB75, SB77, SB78, SB85, SB102, SB115, SB133, SB140, SB148, SB151, SB165, SB169, SB170, SB185, SB197, SB200, SB217, SB235, SB278, SB280, SB291, SB300, SB303, SB315, SB324, SB330, SB411, SB416, SB420, SB436, SB438, SB449, SB455, SB456, SB477, SB489, SB521, SB97, SB105, HR171, HCR49, HCR65, HCR72, HR37, HCR64, HR170, HR191, HR206, HR207, HR208, HR217, HCR11, HCR53, HCR60, HCR66, HCR68, SCR19, SCR3, SCR6, SCR18, SCR11, SCR22, SCR2, HCR6, HB64, HB68, HB92, HB130, HB258, HB633, HB801, HB61, HB98, HB102, HB139, HB142, HB170, HB185, HB194, HB199, HB231, HB247, HB294, HB336, HB474, HB661, HB842, HB852, HB66, HB153, HB165, HB326, HB387, HB455, HB513, HB603, HB660, HB719, HB762, HB766, HB802, HB816, HB833, HB940, HB950, HB975, HB1028, HB1039, HB1051, HB1053, HB1080, HB1201, HB1215, HB1228, HB1251, HB1252, SB1, SB23, SB32, SB42, SB43, SB46, SB51, SB110, SB113, SB150, SB154, SB161, SB218, SB220, SB221, SB253, SB289, SB310, SB351, SB399, SB404, SB502, SB26, SB28, SB29, SB30, SB41, SB44, SB64, SB84, SB87, SB93, SB98, SB107, SB118, SB142, SB192, SB195, SB199, SB219, SB222, SB234, SB241, SB255, SB275, SB277, SB292, SB294, SB306, SB314, SB482, HCR32, HB798, HB998, HB1084, HB1223, HB59, HB955, HB1191, HB1234, HB646, HB824, HB341, SB397, SB442, HB901, HB79, HR20, HR74, HB284, HB306, HB366, HB393, HB458, HB577, HB582, HB605, HB614, HB682, HB733, HB752, HB773, HB911, HB926, HB996, HB1035, HB1069, HB1113, HB1140, HB1180, HB1240, SB47, SB82, SB89, SB149, SB382
OK
Transcript Highlights:
  • investigative treatments, custom therapies derived from their unique genetic profiles, outside of the standard FDA
Summary: The House convened under quorum call and began with several recognitions and presentations, including visits from Comanche County 4-H, the Muskogee Police Department officers who completed EMT training, the March of Dimes, and Ag Day honorees, including the Ag Hall of Fame recipient Ron Justice. The chamber also adopted House Resolution 1054 designating April 2026 as Library Month, with a special presentation honoring library leaders and advocates for their work on the first Library Day at the Capitol. The House then considered and passed a series of bills, mostly on broad bipartisan votes, covering state symbols, fireworks sales, oil and gas royalty protections, AP exam access, veteran records access for grandchildren, Medicaid support for a food-is-medicine grant, law library representation, controlled substances, public health, state security staffing, financial exploitation protections, credit union modernization, workforce data, staffing contracts, enterprise zone incentives, conveyance/title theft protections, hospice narcotics disposal, duplicate statute cleanup, and memorial highway/bridge designations. One major bill, SB 237 on eliminating the solar and battery storage manufacturing tax exemption, was laid over after discussion and questions about tax policy and local incentives. Several measures drew brief explanation and questions, including SB 2159 on state symbols and wheat, SB 1948 on fireworks sales, HB 1371 on oil and gas royalty payments and bankruptcy protections, SB 1975 on AP testing locations, SB 2026 on access to veterans’ discharge papers, SB 1565 on food-is-medicine Medicaid support, SB 1642 on splitting short opioid prescriptions, and SB 933 creating a right-to-try pathway for individualized treatment. Most of these bills passed with little or no debate, and several emergency clauses also passed by the required two-thirds vote. Not all measures advanced: SB 1771, expanding Workforce Commission data authority, failed on a 27-46 vote, and the House later gave notice of intent to reconsider. SB 1365 was reconsidered and then passed, but its emergency clause failed. The session also featured an extended personal privilege speech by Rep. Scott Fetgatter marking his departure, in which he thanked colleagues and staff and reflected on his tenure and legislative work.
NM
NM

New Mexico 2025 Regular Session

IC - Water and Natural Resources Aug 18th, 2025

Water & Natural Resources Committee

Transcript Highlights:
  • So, with a 39% cut to FDA produce safety funding, how will the department maintain Oversight in order
FL

Florida 2025 Regular Session

Senate in Session Apr 28th, 2025

Florida Senate Floor Meeting

Transcript Highlights:
  • Up in the East Gallery, we have General Retired and our own FDA bold and glorious leader, Hammer Hartsell
Bills: SCR46, SB31, SB39, SB227, SB330, SB401, SB407, SB467, SB482, SB500, SB506, SB512, SB527, SB584, SB619, SB636, SB646, SB647, SB648, SB659, SB663, SB715, SB732, SB758, SB801, SB816, SB847, SB870, SB884, SB1020, SB1055, SB1065, SB1137, SB1169, SB1181, SB1283, SB1383, SB1395, SB1410, SB1433, SB1490, SB1558, SB1574, SB1626, SB1666, SB1718, SB1727, SB1756, SB1757, SB1845, SB1924, SB1964, SB1972, SB2018, SB2031, SB2075, SB2076, SB2080, SB2111, SB2117, SB2154, SB2161, SB2173, SB2206, SB2225, SB2253, SB2268, SB2314, SB2322, SB2351, SB2371, SB2476, SB2533, SB2540, SB2570, SB2589, SB2623, SB2658, SB2660, SB2692, SB2693, SB2717, SB2722, SB2753, SB2779, SB2877, SB2880, SB2900, SB2920, SB3031, HJR4, SB5, SB260, SB1786, SJR3, SJR18, SB1, SJR36, SJR50, SJR63, SJR84, SJR59, SCR12, SCR39, SCR46, SCR48, SCR19, SB2023, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB1502, SB507, SB1026, SB1433, SB1434, SB1376, SB1585, SB1772, SB2016, SB1163, SB619, SB1122, SB732, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB529, SB209, SB2429, SB1999, SB511, SB2309, SB510, SB1924, SB2253, SB2018, SB2206, SB584, SB1085, SB1490, SB2314, SB2046, SB1975, SB2717, SB1262, SB1524, SB1137, SB636, SB2056, SB1558, SB884, SB227, SB517, SB1200, SB1410, SB1626, SB1845, SB1863, SB2681, SB2200, SB2199, SB1757, SB2050, SB2458, SB2201, SB1055, SB2660, SB2662, SB1065, SB801, SB2533, SB3014, SB3013, SB758, SB648, SB647, SB512, SB1721, SB2268, SB2366, SB1013, SB2692, SB2570, SB2797, SB2111, SB2371, SB2383, SB646, SB1169, SB1754, SB1718, SB2779, SB2004, SB1756, SB2119, SB527, SB2322, SB2448, SB1777, SB1283, SB407, SB2392, SB2076, SB2786, SB3031, SB2877, SB2876, SB2284, SB2225, SB1540, SB2920, SB2929, SB1395, SB1972, SB2540, SB2742, SB2595, SB2217, SB2117, SB715, SB2330, SB1964, SB1383, SB500, SB1640, SB2001, SB2080, SB2722, SB506, SB2514, SB2623, SB2658, SB1574, SB2900, SB2753, SB2398, SB401, SB1241, SB2927, SB2173, SB2538, SB898, SB467, SB1449, SB2529, SB1531, SB2846, SB2476, SB2031, SB986, SB1181, SB2075, SB2154, SB2864, SB31, SB2880, SB1359, SB2386, SB771, SB2844, SB2550, SB1351, SB1423, SB1931, SB2245, SB2589, SB2707, SB2807, SB2351, SB410, SB659, SB816, SB2776, SB2693, SB2580, SB1980, SB1886, SB1234, SB739, SB482, SB456, SB127, SB1666, SB2843, SB2801, SB800, SB2055, SB784, SB2986, SB735, SB1012, SB324, SB2926, SB2938, SB2007, SB2138, SB1242, HJR4, HB135, HB 1109, SCR30, SCR3, SB2615, SB1049, SB2310, SB1224, SB2972, SB1568, SB2841, SB2885, SB3016, SB2858, SB2610, SB2139, SB1856, SB2035, SB2308, SB2306, SB2041, SB1528, SB1681, SB1141, SB2401, SB2530, SB2375, SB547, SB1266, SB1373, SB1467, SB2069, SB2269, SB2480, SB2544, SB672, SB904, SB2695, SB2891, SB2422, SB2543, SB1854, SB317, SB2539, SB2532, SB2925, SB1250, SB2082, SB2203, SB457, SB2357, HCR35, HCR64, SB227, SB401, SB512, SB527, SB648, SB1490, SB1558, SB1574, SB1626, SB1756, SB1924, SB1964, SB2018, SB2031, SB2111, SB2117, SB2206, SB2570, SB2658, SB2692, SB2900, SB3031, SB407, SB1395, SB1433, SB1718, SB2322, SB2877, SR453, SR461, SJR86, SB3060, SB3061, HB18, HB26, HB36, HB37, HB48, HB 126, HB150, HB252, HB503, HB517, HB581, HB742, HB754, HB972, HB 1024, HB 1041, HB 1089, HB1442, HB1562, HB1633, HB1689, HB1690, HB1696, HB1718, HB1732, HB1741, HB2103, HB2216, HB2733, HB2884, HB2986, HB3700, SB1888, SJR86, SB3060, SB3061, HB18, HB26, HB36, HB37, HB48, HB 126, HB150, HB252, HB503, HB517, HB581, HB742, HB754, HB972, HB 1024, HB 1041, HB 1089, HB1442, HB1562, HB1633, HB1689, HB1690, HB1696, HB1718, HB1732, HB1741, HB2103, HB2216, HB2733, HB2884, HB2986, HB3700, SB1888
TX

Texas 89th Regular

Senate Session Mar 31st, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • I understand that maybe the FDA will have something to say about it, but if a bill like this were to
Bills: SJR37, SJR57, SB7, SB8, SB16, SB108, SB125, SB207, SB318, SB371, SB379, SB396, SB406, SB503, SB533, SB565, SB578, SB599, SB686, SB689, SB707, SB763, SB854, SB857, SB875, SB878, SB920, SB924, SB961, SB965, SB985, SB988, SB1021, SB1024, SB1026, SB1038, SB1059, SB1185, SB1202, SB1207, SB1252, SB1330, SB1396, SB1484, SB1527, SB1535, SB1596, SB1619, SB1697, SB1737, SB1741, SB1841, SJR36, SJR12, SJR57, SJR37, SCR22, SCR12, SB565, SB765, SB62, SB666, SB707, SB888, SB687, SB847, SB1248, SB504, SB857, SB305, SB296, SB284, SB1497, SB1498, SB241, SB304, SB621, SB1023, SB1024, SB686, SB371, SB204, SB609, SB670, SB850, SB854, SB413, SB1346, SB1033, SB1220, SB1073, SB810, SB1539, SB447, SB875, SB406, SB985, SB965, SB1119, SB1505, SB1215, SB1302, SB856, SB583, SB673, SB681, SB1172, SB1252, SB608, SB955, SB957, SB988, SB1021, SB1120, SB251, SB541, SB379, SB1737, SB266, SB1415, SB1527, SB125, SB599, SB1330, SB53, SB1352, SB785, SB472, SB1450, SB1502, SB1566, SB414, SB1062, SB961, SB1038, SB578, SB711, SB746, SB942, SB1404, SB1448, SB1738, SB108, SB8, SB318, SB507, SB533, SB689, SB1026, SB1349, SB1355, SB1433, SB1434, SB1596, SB1403, SB763, SB667, SB1059, SB617, SB1567, SB503, SB16, SB310, SB311, SB396, SB505, SB1209, SB1210, SB1470, SB264, SB924, SB1029, SB1185, SB1202, SB1358, SB1364, SB1569, SB1697, SB1376, SB1228, SB519, SB878, SB1350, SB462, SB1535, SB827, SB1585, SB207, SB1207, SB1619, SB1396, SB920, SB1484, SB1273, SB1741, SB7, SB927, SB1227, SB1229, SB1353, SB1366, SB1464, SB1709, SB1729, SB1733, SB1744, SB1772, SB1816, SB1841, SB2188, SB1147, SB879, SB1008, SJR81, SJR50, SCR39, SB1536, SB2016, SB1453, SB1173, SB1163, SB996, SB27, SB568, SB1370, SB1321, SB1101, SB906, SB860, SB1563, SB993, SB693, SB1610, SB1537, SB836, SB1332, SB1307, SB963, SB493, SB922, SB984, SB1084, SB619, SB1098, SB1122, SB455, SB522, SB1057, SB1239, SB1254, SB1255, SB1259, SB1341, SB1664, SB1877, SB464, SB1277, SB32, SB732, SB660, SB731, SB921, SB268, SB1822, SB1188, SB1939, SB1589, SB397, SB1388, SB2230, SB1058, SB1036, SB1267, SB2112, SB1930, SB532, SB1035, SB2155, SB508, SB29, SB292, SB291, SB901, SB1333, SB1436, SB1494, SB964, SB779, SB1378, SB2312, SB1719
AL
Transcript Highlights:
  • That's the need to run the program without any hidden drug costs that may be coming down that the FDA
  • coming<02:57:48.640> down<02:57:48.880> that<02:57:49.120> the<02:57:49.279> FDA
  • <02:57:49.760> may may be coming down that the FDA may may be coming down that the FDA may
Keywords: 924, joint, all
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on the Judiciary Jun 21st, 2026 at 01:00 pm

Joint Committee on the Judiciary

Transcript Highlights:
  • Additionally, the FDA regulatory guidelines for state of chemical and dietary science is a clear temidavitia
Keywords: 995, all
Summary: The hearing covered a wide range of Judiciary Committee bills, with much of the testimony focused on criminal justice, public safety, and civil asset forfeiture reform. Several lawmakers and advocates supported bills to increase penalties or create new offenses related to assaults on sports officials, assaults on transit workers, reckless discharge of firearms, fires and explosives, pill press machines, and drug-induced homicide. Testifiers described rising harassment and violence against youth sports officials and transit workers, as well as the fentanyl overdose crisis and the need for stronger tools to prosecute dealers whose conduct leads to death. Supporters of the sports-official and transit-worker bills emphasized declining referee availability and repeated assaults on commuter rail and MBTA workers. District attorneys also backed bills on reckless firearm discharge and fires/explosives, saying current law does not adequately address dangerous conduct that endangers bystanders. The committee also heard testimony on several proposals related to youth diversion and prison mitigation. Supporters of the youth court justice fund bill said youth courts are peer-led diversion programs with strong compliance and low recidivism, and argued for a stable funding source rather than annual earmarks. A representative from Bridgewater supported a prison mitigation fund for municipalities that host state prisons, saying the costs of public safety and emergency services are not fully covered. On gun policy, testimony split between supporters of a bill to ban in-state manufacture of assault-style rifles for civilian sale and opponents or skeptics of other firearm-related measures, including a bill on collateralizing firearms and a bill to increase penalties for drug trafficking combined with illegal firearm offenses. A major portion of the hearing was devoted to civil asset forfeiture reform. Advocates from the ACLU, CPCS, the Boston Bar Association, the Institute for Justice, and others supported bills to increase the burden of proof, improve transparency and reporting, require counsel, and limit or eliminate the current practice of directing forfeiture proceeds to law enforcement. They argued the current system creates perverse incentives, lacks adequate due process, and is insufficiently transparent. District Attorney Paul Tucker defended current forfeiture practices, saying his office has reporting and oversight, uses the funds for investigations and community programs, and warned that reducing forfeiture revenue would hinder crime fighting. No votes or final committee actions were taken during the hearing; the chairs repeatedly thanked witnesses and indicated the bills would remain under consideration.
NM

New Mexico 2026 Regular Session

House - Appropriations and Finance Jan 13th, 2026 at 09:00 am

House Appropriations & Finance

Transcript Highlights:
  • For example, we just had a gentleman the other day have a new non-FDA approved drug found in his horse
Keywords: 996, all
NM

New Mexico 2025 Regular Session

IC - Legislative Health and Human Services Nov 5th, 2025

Legislative Health & Human Services Committee

Transcript Highlights:
  • However, every single state except Florida is still awaiting FDA approval.
NM

New Mexico 2025 Regular Session

House - Health and Human Services Feb 3rd, 2025

House Health & Human Services

Transcript Highlights:
  • The vagus nerve stimulation is FDA-approved and one of the best treatments that we have for patients
NH

New Hampshire 2026 Regular Session

House Science, Technology and Energy (01/27/2026)

Science, Technology and Energy

Transcript Highlights:
  • It's also regulated by the EPA, the FDA, the National Institute for Occupational Safety and Health, and
  • It's also regulated by the EPA, the FDA, the National Institute for Occupational Safety and Health, and
  • by<01:36:57.280> the<01:36:57.520> EPA,<01:36:58.159> the<01:36:58.400> FDA
  • , it's also regulated by the EPA, the FDA, it's also regulated by the EPA, the FDA, the<01:36:59.360
Keywords: 1189, house, all
US

US Federal 2025-2026 Regular Session

US House Floor Proceedings (Wednesday, June 10, 2026)

US Federal House Floor Meeting

Transcript Highlights:
  • earned his bachelor's, master's, and PhD in chemistry from the University of Cincinnati and joined the FDA
  • His forensic work in the 1980s Tylenol tampering crisis helped establish the FDA Forensic Chemistry Center
  • With over 40 publications, two U.S. patents, and dozens of FDA honors, Dr.